S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Secret Bull Market Starts in This Unusual Sector (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Your Money is Not Safe (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Urgent alert: open this for a huge profit potential (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Secret Bull Market Starts in This Unusual Sector (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Your Money is Not Safe (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Urgent alert: open this for a huge profit potential (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Secret Bull Market Starts in This Unusual Sector (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Your Money is Not Safe (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Urgent alert: open this for a huge profit potential (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Secret Bull Market Starts in This Unusual Sector (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Your Money is Not Safe (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Urgent alert: open this for a huge profit potential (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
Free Trial
ETR:EVT

Evotec (EVT) Stock Price, News & Analysis

→ Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad)
Free EVT Stock Alerts
€13.26
-0.19 (-1.41%)
(As of 04/19/2024 ET)
Compare
Today's Range
€12.94
▼
€13.27
50-Day Range
€12.62
▼
€14.47
52-Week Range
€12.61
▼
€24.44
Volume
673,258 shs
Average Volume
1.36 million shs
Market Capitalization
$2.35 billion
P/E Ratio
N/A
Dividend Yield
2.63%
Price Target
N/A
Stock AnalysisChartHeadlines
EVT stock logo

About Evotec Stock (ETR:EVT)

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer; Lilly; Almirall; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Janseen Biotech; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals, as well as a strategic partnership with Dewpoint Therapeutics to advance oncology pipeline programs of condensate modifying therapeutics to investigational new drug applications and a licensing agreement with Glycotope GmbH to develop next generation immune cell engaging bispecifics for various potential indications, including solid tumors The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

EVT Stock Price History

EVT Stock News Headlines

April 18, 2024 | markets.businessinsider.com
EQS-News: Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments
April 17, 2024 | finanznachrichten.de
Evotec beruft Aurélie Dalbiez in den Vorstand
April 20, 2024 | American Alternative (Ad)
Your Money is Not Safe
Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…
April 17, 2024 | finanznachrichten.de
Evotec SE: Evotec welcomes Aurélie Dalbiez as Chief People Officer
April 17, 2024 | markets.businessinsider.com
EQS-News: Evotec welcomes Aurélie Dalbiez as Chief People Officer
April 17, 2024 | finance.yahoo.com
Evotec SE to Announce Results for Fiscal Year 2023 on 24 April 2024
April 13, 2024 | finanznachrichten.de
ANALYSE: Deutsche Bank hebt Evotec auf 'Buy' - Frust nach Chef-Abgang überwunden
March 29, 2024 | finanznachrichten.de
Biotech Report: Evotec klettern, Qiagen fest
April 20, 2024 | American Alternative (Ad)
Your Money is Not Safe
Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…
March 15, 2024 | finanznachrichten.de
Evotec-Aktie: Das wird spannend
March 6, 2024 | markets.businessinsider.com
EQS-News: Evotec and Claris Ventures streamline access to accelerate programmes from Claris's portfolio companies into the clinic
February 22, 2024 | finanznachrichten.de
Evotec Aktie sucht Boden: Kommt jetzt die große Wende nach oben?Evotec Aktie sucht Boden: Kommt jetzt die große Wende nach oben?
February 6, 2024 | finanznachrichten.de
Evotec: Aktie fällt und fällt - das ist jetzt wichtig
February 3, 2024 | finanznachrichten.de
Evotec-Aktie fällt unter wichtige Marke. Wie sollen Anleger jetzt reagieren?
January 22, 2024 | finance.yahoo.com
Evotec SE: Invitation to Conference Call
January 8, 2024 | markets.businessinsider.com
EQS-News: Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb
January 8, 2024 | finance.yahoo.com
Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb
January 3, 2024 | markets.businessinsider.com
EQS-Adhoc: Evotec announces CEO transition
January 3, 2024 | finanznachrichten.de
Evotec SE: Evotec Announces CEO Transition
January 3, 2024 | markets.businessinsider.com
EQS-News: Evotec announces CEO transition
January 3, 2024 | finance.yahoo.com
Evotec Announces CEO Transition
December 14, 2023 | finance.yahoo.com
Evotec Enters Partnership with Charité to Expand Molecular Patient Database in Autoimmune Diseases
December 6, 2023 | msn.com
Evotec partner Jingxin receives approval for EVT201 in China
December 6, 2023 | markets.businessinsider.com
EQS-News: Evotec-partner Jingxin receives approval for EVT201 in China
November 8, 2023 | markets.businessinsider.com
Evotec 9-month Adj. EBITDA, Revenues Rise; Confirms FY23, Mid-term Outlook
November 8, 2023 | finance.yahoo.com
Evotec SE Reports Results for the First Nine Months 2023 and Provides Corporate Update
November 7, 2023 | fxstreet.com
Flat start to Monday after global equities posted best week in a year
See More Headlines
Receive EVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evotec and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
ETR
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
ETR:EVT
CUSIP
N/A
CIK
N/A
Web
www.evotec.com
Phone
+49-40-560810
Fax
N/A
Employees
5,086
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
(€0.53)
Trailing P/E Ratio
N/A
Forward P/E Ratio
63.84
P/E Growth
0.98
Net Income
$-94,980,000.00
Net Margins
-11.57%
Pretax Margin
N/A
Return on Equity
-8.02%
Return on Assets
0.17%

Debt

Debt-to-Equity Ratio
51.61
Current Ratio
2.16
Quick Ratio
2.97

Sales & Book Value

Annual Sales
$820.80 million
Price / Sales
2.90
Cash Flow
€3.90 per share
Price / Cash Flow
3.45
Book Value
€6.45 per share
Price / Book
2.09

Miscellaneous

Outstanding Shares
177,190,000
Free Float
N/A
Market Cap
$2.38 billion
Optionable
Not Optionable
Beta
1.11
Investing Strategies To Help Grow Your Retirement Income Cover
Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Dr. Mario Polywka DPHIL (Age 61)
    Ph.D., Interim CEO, Member of the Management Board & Member of the Supervisory Board
  • Dr. Werner Lanthaler M.B.A. (Age 56)
    MPA, Ph.D., Member of Management Board
    Comp: $1.32M
  • Dr. Cord Dohrmann Ph.D. (Age 60)
    Chief Scientific Officer & Member of Management Board
    Comp: $804k
  • Dr. Craig Johnstone Ph.D. (Age 54)
    COO & Member of Management Board
    Comp: $712k
  • Dr. Matthias Evers Ph.D. (Age 51)
    Chief Business Officer & Member of Management Board
    Comp: $636k
  • Ms. Laetitia Rouxel (Age 50)
    CFO & Member of Management Board
  • Ms. Anja Bosler
    Principal Accounting Officer and Senior Vice President of Group Accounting
  • Mr. Volker Braun
    Senior VP and Global Head of Investor Relations & ESG
  • Dr. Christian Dargel
    EVP Global Head of Legal & Compliance
  • Gabriele Hansen
    Senior VP & Head of Global Corporate Communications & Marketing

Key Competitors

View All Competitors

EVT Stock Analysis - Frequently Asked Questions

How have EVT shares performed in 2024?

Evotec's stock was trading at €21.28 on January 1st, 2024. Since then, EVT shares have decreased by 36.8% and is now trading at €13.45.
View the best growth stocks for 2024 here.

What other stocks do shareholders of Evotec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Evotec investors own include Agilent Technologies (A), AbbVie (ABBV), ACADIA Pharmaceuticals (ACAD), Anthem (ANTM), AxoGen (AXGN), Bank of America (BAC), Booz Allen Hamilton (BAH), Biohaven (BHVN), Biogen (BIIB) and Blueprint Medicines (BPMC).

This page (ETR:EVT) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
How Biden has already won 2024
Porter & Company
Top 5 AI Stocks to Buy for 2024
Market Moving Trends